Two deaths reported in Japan in patients receiving liraglutide
This article was originally published in Scrip
Executive Summary
Novo Nordisk has informed the regulatory authorities and medical professionals in Japan of the deaths of two patients who had been administered the company's novel antidiabetic Victoza (liraglutide).